Anticoagulant Citrate Dextrose A ACD-A is a Extracorporeal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Arteriocyte Medical Systems, Inc.. The primary component is Citric Acid Monohydrate; Sodium Citrate, Unspecified Form; Dextrose Monohydrate.
| Product ID | 43203-852_36fd228c-a0de-42d9-90a4-c7b252a07571 |
| NDC | 43203-852 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Anticoagulant Citrate Dextrose A ACD-A |
| Generic Name | Anticoagulant Citrate Dextrose A Acd-a |
| Dosage Form | Injection, Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 2011-05-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | BA110057 |
| Labeler Name | Arteriocyte Medical Systems, Inc. |
| Substance Name | CITRIC ACID MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM; DEXTROSE MONOHYDRATE |
| Active Ingredient Strength | 0 g/10mL; g/10mL; g/10mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |